The Turkish Journal of Geriatrics (Türk Geriatri Dergisi), with ISSN 1304-2947 and E-ISSN 1307-9948, is a distinguished scholarly publication dedicated to the field of geriatrics and gerontology, proudly published by the Turkish Geriatrics Society. Established to foster knowledge and research in the aging population, this journal plays a crucial role in disseminating significant findings and advancements in the medical care of elderly individuals. Since its inception in 1998, the journal has committed to high-quality, peer-reviewed articles that explore diverse aspects of geriatric medicine, contributing vital insights to practitioners and researchers alike. Although it currently holds a Q4 ranking in the category of Geriatrics and Gerontology, the Turkish Journal of Geriatrics is on an upward trajectory, making it an essential resource for those specializing in the care of older adults. Researchers and professionals are encouraged to explore its rich archive and benefit from the open-access publishing model, promoting broader access to impactful research. For those invested in the well-being of the elderly, the Turkish Journal of Geriatrics serves not only as a platform for scholarly communication but also as a catalyst for innovation in geriatric care.

Geriatrics is a leading academic journal committed to advancing the understanding and research within the expansive field of gerontology and geriatric medicine. Published by MDPI since 2016 and featuring an Open Access model, this journal aims to disseminate high-quality research that addresses the challenges and opportunities associated with aging populations. Based in Switzerland, Geriatrics has rapidly gained recognition, achieving notable rankings in various categories such as Q2 in Gerontology and Q3 in both Aging and Geriatrics and Gerontology, making its contributions significant within the scholarly community. The journal welcomes original articles, reviews, and case studies, focusing not only on clinical aspects but also on social science perspectives related to health. Researchers and professionals in the field will find this journal a vital resource for the latest insights and trends that are crucial to improving elderly care and enhancing quality of life for aging individuals globally. With its commitment to open access, Geriatrics ensures that crucial research findings are readily available to all stakeholders, thus promoting informed dialogue and collaboration across disciplines.

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, published by SPRINGER HEIDELBERG, is an authoritative journal dedicated to advancing the field of geriatrics and gerontology. With its ISSN 0948-6704 and E-ISSN 1435-1269, this journal has been a significant source of scholarly articles since its inception in 1995, catering to researchers and practitioners amid the growing importance of ageing studies. While it currently holds a Q4 ranking in Geriatrics and Gerontology and a Q3 ranking in Gerontology and Social Sciences, its contribution spans vital topics related to health ethics and legal aspects—reflecting a comprehensive view of the challenges faced in elder care. Although it is not an open-access journal, its rigorous peer-review process ensures that the research published is of high quality and relevance. Based in Heidelberg, Germany, the journal aims to foster discourse and disseminate crucial research findings that impact the health of elderly populations, making it an essential resource for researchers, healthcare professionals, and students devoted to improving geriatric care and understanding the complexities associated with ageing.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

AGE AND AGEING is a premier peer-reviewed journal published by Oxford University Press, dedicated to advancing the field of gerontology and related medical disciplines. With its ISSN of 0002-0729 and E-ISSN 1468-2834, the journal has established itself as a critical platform for disseminating innovative research since its inception in 1972. It boasts impressive rankings within the Q1 category in Aging, Geriatrics and Gerontology, and Miscellaneous Medicine, reflecting its influential position in the scientific community. Researchers and practitioners alike value the journal's focus on the clinical, biological, and social aspects of aging, providing a multidisciplinary approach essential for addressing the challenges of an aging population. The journal maintains a significant impact factor, demonstrating its contribution to scholarly communication and knowledge dissemination. Although it does not operate under an open access model, AGE AND AGEING remains an essential resource for those committed to understanding the complexities of aging and enhancing the quality of life for older adults.

Clinical Interventions in Aging is a premier Open Access journal published by DOVE MEDICAL PRESS LTD that has been at the forefront of geriatric research since its inception in 2006. With its core focus on innovative interventions and evidence-based practices to enhance the quality of life for the elderly, this journal serves as a vital resource for researchers, healthcare professionals, and students in the fields of geriatrics and gerontology. The journal boasts a commendable impact factor, achieving a Q2 ranking in Geriatrics and Gerontology and a Q1 ranking in Medicine (miscellaneous) as of 2023, highlighting its significant academic contribution. Notably, its Scopus ranking places it in the top 31% of its category, underscoring the relevance and quality of the research it publishes. With a commitment to advancing knowledge, this journal not only promotes accessibility through its Open Access model but also ensures that cutting-edge studies are readily available to those dedicated to improving geriatric care. Located in Auckland, New Zealand, the journal continues to expand its influence globally, making it an essential platform for discussions surrounding aging and health.

Aging Medicine, published by Wiley, is a pivotal open-access journal that has been at the forefront of research dedicated to the aging population since its inception in 2018. With a focus on both geriatric care and gerontology, the journal serves as a crucial resource for researchers, healthcare professionals, and students interested in understanding the complexities of aging and the related medical challenges. Although it holds a Q3 quartile ranking in the fields of Aging and Geriatrics and Gerontology according to the 2023 metrics, the journal continues to effectively disseminate valuable research and insights, helping to bridge gaps in knowledge and practice. With an E-ISSN of 2475-0360, it offers an open-access model that ensures broader accessibility to its published content, thus promoting collaboration and innovation across disciplines. As the journal converges towards 2024, it remains committed to evolving with the dynamics of aging research, making it a significant platform for the exchange of ideas and advancements in this essential field.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, published by SAGE PUBLICATIONS LTD, is a pivotal resource in the fields of oncology, pharmacology, and medicine, with a dedicated focus on the evolving discipline of oncology pharmacy. Based in the United Kingdom, this journal has been diligently serving its readers since 1995 and continues to explore the intersection of pharmaceutical care and cancer treatment, showcasing innovative practices, research findings, and clinical advancements that are indispensable for healthcare professionals, researchers, and students alike. Although not an open-access journal, it holds a respectable Category Quartile Q3 ranking across its various fields, including Medicine, Oncology, and Pharmacology, indicating its relevance in nurturing academic discourse and addressing critical issues in cancer care. With an ISSN of 1078-1552 and E-ISSN of 1477-092X, the journal invites contributions that enhance the understanding of pharmaceutical interventions in oncology, aiming to improve therapeutic outcomes and patient care. Join a global community of professionals committed to excellence in oncology pharmacy practice and stay informed with cutting-edge research and reviews that significantly impact patient healthcare strategies.

DRUGS IN R&D is a premier open access journal dedicated to advancing the field of pharmacology and drug development. Published by Springer International Publishing AG, this journal has been a valuable resource for researchers and professionals since its inception in 1999, contributing critical insights into the pharmacological sciences. With an impressive Impact Factor reflecting its significance, DRUGS IN R&D ranks in the Q2 quartile for Pharmacology, according to 2023 metrics, and ranks #151 out of 313 in the field of pharmacology and toxicology on Scopus. This journal offers an open access format, ensuring high visibility and accessibility of research findings to a global audience, supporting the intrepid pursuit of knowledge in drug research and development. By facilitating comprehensive discussions and innovative research findings, DRUGS IN R&D plays a crucial role in shaping the future landscape of pharmacological studies and advancements.

Aging Medicine and Healthcare is a leading Open Access journal dedicated to advancing the understanding of geriatric health and the complexities of aging. Published by the Asia Pacific League Clinical Gerontology & Geriatrics, this innovative journal began its journey in 2019 and has since established itself as an important resource for healthcare professionals, researchers, and students interested in the fields of geriatrics and gerontology. With an impact factor that reflects its growing significance (ranked in the 21st percentile within its category), the journal aims to disseminate high-quality research and practical insights that can inform clinical practice and enhance patient care for aging populations. As an Open Access publication, it ensures that research findings are freely accessible, fostering collaboration and knowledge sharing among academics and practitioners globally. The journal is poised to be a vital platform for innovative studies, systematic reviews, and case reports that illuminate the challenges and opportunities in aging medicine.